Bahloul, E <br/><br/>
Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases.  [electronic resource] 

 -  Lupus  Oct 2017 
 - 1304-1308 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1477-0962 
<br/><br/><label>Standard No.: </label>10.1177/0961203317700486  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anticoagulants--administration & dosage<br/>Antimalarials--administration & dosage<br/>Antirheumatic Agents--administration & dosage<br/>Cross-Sectional Studies<br/>Female<br/>Humans<br/>Hydroxychloroquine--administration & dosage<br/>Hyperpigmentation--chemically induced<br/>Lupus Erythematosus, Systemic--drug therapy<br/>Male<br/>Middle Aged<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Prevalence<br/>Risk Factors<br/>Surveys and Questionnaires<br/>Time Factors<br/>Young Adult